Evidence map›Paper›PMID 29036586›Full record

ArticleNucleic acids research2017

Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone.

Yehoshua Enuka, Morris E Feldman, Animesh Chowdhury, Swati Srivastava, Moshit Lindzen, Aldema Sas-Chen, Renaud Massart, David Cheishvili, Matthew J Suderman, Yoav Zaltsman and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Butyrate SilencesAllergy, asthma & immunology research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Chromatin reprogramming in breast cancer.Endocrine-related cancer · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 4 countries.

Yehoshua EnukaDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Morris E FeldmanDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Animesh ChowdhuryDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Swati SrivastavaDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Moshit LindzenDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Aldema Sas-ChenDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Renaud MassartDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada.
David CheishviliDepartment of Pharmacology and Therapeutics, Sackler Program for Epigenetics and Developmental Psychobiology and McGill Centre for Bioinformatics, McGill University, Montreal, Quebec, Canada.
Matthew J SudermanDepartment of Pharmacology and Therapeutics, Sackler Program for Epigenetics and Developmental Psychobiology and McGill Centre for Bioinformatics, McGill University, Montreal, Quebec, Canada.
Yoav ZaltsmanDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Chiara A MazzaDepartment of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Bologna 40126, Italy.
Kirti ShuklaDivision of Molecular Genome Analysis, German Cancer Research Center, Heidelberg, Germany.
Cindy KörnerDivision of Molecular Genome Analysis, German Cancer Research Center, Heidelberg, Germany.
Noa FurthDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Mattia LauriolaDepartment of Experimental, Diagnostic and Specialty Medicine (DIMES), Unit of Histology, Embryology and Applied Biology, University of Bologna, Bologna 40126, Italy.
Moshe OrenDepartment of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel.
Stefan WiemannDivision of Molecular Genome Analysis, German Cancer Research Center, Heidelberg, Germany.
Moshe SzyfDepartment of Pharmacology and Therapeutics, Sackler Program for Epigenetics and Developmental Psychobiology and McGill Centre for Bioinformatics, McGill University, Montreal, Quebec, Canada.
Yosef YardenDepartment of Biological Regulation, Weizmann Institute of Science, Rehovot 76100, Israel.
Weizmann Institute of Science · ILMcGill University · CAGerman Cancer Research Center · DEUniversity of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crosstalk between growth factors (GFs) and steroid hormones recurs in embryogenesis and is co-opted in pathology, but underlying mechanisms remain elusive. Our data from mammary cells imply that the crosstalk between the epidermal GF and glucocorticoids (GCs) involves transcription factors like p53 and NF-κB, along with reduced pausing and traveling of RNA polymerase II (RNAPII) at both promoters and bodies of GF-inducible genes. Essentially, GCs inhibit positive feedback loops activated by GFs and stimulate the reciprocal inhibitory loops. As expected, no alterations in DNA methylation accompany the transcriptional events instigated by either stimulus, but forced demethylation of regulatory regions broadened the repertoire of GF-inducible genes. We report that enhancers, like some promoters, are poised for activation by GFs and GCs. In addition, within the cooperative interface of the crosstalk, GFs enhance binding of the GC receptor to DNA and, in synergy with GCs, promote productive RNAPII elongation. Reciprocally, within the antagonistic interface GFs hyper-acetylate chromatin at unmethylated promoters and enhancers of genes involved in motility, but GCs hypoacetylate the corresponding regions. In conclusion, unmethylated genomic regions that encode feedback regulatory modules and differentially recruit RNAPII and acetylases/deacetylases underlie the crosstalk between GFs and a steroid hormone.

Indexed as

Epigenesis, GeneticCell LineCell MovementDexamethasoneDNA MethylationEpidermal Growth FactorGene Expression RegulationGlucocorticoidsHumansNF-kappa BPromoter Regions, GeneticProtein Processing, Post-TranslationalRNA Polymerase IITranscription FactorsTumor Suppressor Protein p53DexamethasoneEpidermal Growth FactorGlucocorticoidsNF-kappa BRNA Polymerase IITranscription FactorsTumor Suppressor Protein p53

Identifiers

PMID29036586
PMCPMC5727445
OpenAlexW2759694364

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.